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Abstract Background: Registries and research on breast cancer in Arabic and developing
countries are limited.
Methods: We searched PubMed, Medline, WHO and IAEA publications, national, regional, hos-
pital tumor registries and abstracts. We reviewed and analyzed available data on epidemiolog-
ical trends and management of breast cancer in Arab countries, and compared it to current
international standards of early detection, surgery and radiation therapy.
Results: Breast cancer constitutes 13e35% of all female cancers. Almost half of patients
are below 50 and median age is 49e52 years as compared to 63 in industrialized nations.
A recent rise of Age-Standardized Incidence Rates (ASR) is noted. Advanced disease
remains very common in Egypt, Tunisia, Saudi Arabia, Syria, Palestinians and others.
Mastectomy is still performed in more than 80% of women with breast cancer. There
are only 84 radiation therapy centers, 256 radiation oncologists and 473 radiation tech-
nologists in all Arab countries, as compared with 1875, 3068 and 5155, respectively, in
the USA, which has an equivalent population of about 300 million. Population-based
screening is rarely practiced. Results from recent campaigns and studies show a positive
impact of clinical breast examination leading to more early diagnosis and breast-
conserving surgery.
Conclusions: Breast cancer is the most common cancer among women in Arab countries
with a young age of around 50 years at presentation. Locally advanced disease is very
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226 N.S. El Saghir et al.common and total mastectomy is the most commonly performed surgery. Awareness
campaigns and value of clinical breast examination were validated in the Cairo Breast
Cancer Screening Trial. More radiation centers and early detection would optimize care
and reduce the currently high rate of total mastectomies. Population-based screening in
those countries with affluent resources and accessible care should be implemented.
ª 2006 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.Introduction
Breast cancer is the most common cancer seen in women,
constituting 22% of all cases worldwide. In 2000, the
estimated number of new cases of breast cancer was
579,000 in developed countries and 471,000 in less de-
veloped countries.1 Many differences with respect to age,
stages at presentation, and biological characteristics exist
between various countries. In the United States, approxi-
mately 50% of all womenwith newly diagnosed breast cancer
are older than 63 years while in many so-called developing
countries almost half of women with newly diagnosed breast
cancer are younger than 50 years of age.2 In-situ disease has
become more common in the developed world3 yet locally
advanced and metastatic diseases at presentation remain
very common in the developing countries.4
The Arab world has a total population of approximately
301,227,000 in the year 2004, living in 22 countries spread
across Northern Africa andWestern Asia, including theMiddle
East.5 Data fromArab countries on breast cancer vary accord-
ing to region and country. Many Arab countries have wit-
nessed great urban development and scattered
industrialization. Political instability, military conflicts, and
poor planning have kept the majority of the Arab peoples
away from enjoying the medical advances of the second
half of the twentieth century. Investment in research has
lagged behind and remained a matter of individual and insti-
tutionalmotivation. Arab countries spend 0.15% of their gross
domestic product on research and development as compared
to theworld average of 1.4%.6 Some countries have allocated
large amounts of money for medicine and research.7 Like
many developing countries, they have had other health prior-
ities such as control of infectious diseases and childhood
illnesses. However, the World Health Organization (WHO)
has recently acknowledged that non-communicable diseases
have become a priority for health care in many developing
countries.8,9 Cancer remains a taboo in most Arab countries.
The recent explosion of knowledge and information through
the media and internet have helped change some attitudes,
but most people still refer to it as ‘‘that other disease’’ and
remain afraid of mentioning it by name.
We undertook this study to determine the particular
aspects and status of research on breast cancer in Arab
countries. We aimed at outlining proficiencies and de-
ficiencies in order to help improve breast cancer care in
Arab developing countries where almost 150 million women
live.
Methods
We searched PubMed, Medline and reviewed published
literature, International Agency for Research on Cancer(IARC) publications, data from national and regional cancer
registries where available, international and regional can-
cer meetings, institutional websites, and International
Atomic Energy Agency records for radiation therapy. We
looked at percentages of breast cancer cases, incidence
rates, age-standardized incidence rates (ASR), stages at
presentation, and methods of diagnosis, availability of fine-
needle aspiration (FNA) and core biopsy, frozen section,
breast conservation versus mastectomy, multimodality
management, availability of screening, mammography,
technical and professional expertise, availability of chemo-
therapy, radiotherapy, hormonal therapy, participation in
international trials, performance of own trials, infrastruc-
ture for supportive care for breast cancer patients and
patient support groups.
Results
Scarcity of data was remarkable. Only three Arab countries
were listed in IARC Cancer in five continents,10 namely
Algeria, Kuwait and Oman. Most countries either have
a national registry or regional registry. Some countries
have no data; Most data are published in peer-reviewed
journals or in local journals, meeting abstracts, or posted
on websites. We summarize all the available information
on breast cancer in Arab countries in Tables 1 and 2.
Breast data from selected countries
Egypt
National Cancer Institute in Cairo registry reported breast
cancer to represent 35.1% of female cancers. An ASR of 49.6
in the region of Gharbiah, Egypt in 2002 was reported.
Extensive disease at presentation was reported.11e15 A re-
cent article about breast cancer in Cairo indicates a higher
than expected detection rate of 8 per 1000 breast cancer
cases upon first screening of a target group of 4116 invited
women aged 35e64 living in a geographically defined area
in Cairo, which suggests that many women in the commu-
nity with early but palpable breast cancer fail to seek med-
ical attention until their cancer is advanced.16 National
Cancer Institute of Cairo data showed breast cancer stages
III and IV to be around 80e90% while it became 60% during
this study. This study showed benefit from clinical breast
examination (CBE) and reduction of the incidence of locally
advanced disease, and improvement of breast-conserving
surgery rates.14
Jordan
In 1997, breast cancer constituted 14.2% of all cancer cases
in women. Crude ASR was calculated at 21.3/100,000 in
1997.17,18
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Country Frequency
data
Year(s) No. of patients
(pts) and type
of registry
ASR (per 100,000) Age at presentation Ref.
Algeria * 1990e1993 * 9.5 * 10
Bahrain * 1982e1994 117 pts * * 48
Egypt 37.50% 2002e2003 Hospital-based * Median age: 49 12
* 2003e2004 Hospital-based * * 12
* * Regional (Alexandria) * * 13
37.6% 1999 Regional (Gharbiah) 15 Median age: 48.7 11
Jordan 14.20% 1997 National 21.3 * 18
Kuwait 34.40% * 258 pts (National) 32.8 78% < 50 20
Saudi Arabia 19.10% 1994e1996 1430 pts (national) 11.2 48.3 34
* 1985e1995 292 pts Median ageZ 42 36
Lebanon 23e35% 1964 Hospital-based 20 * 25
27% 1984 1094 pts (National) * * 26
35% 1982e2000 2673 pts (hospital-based) 30.6 Median age: 49;
49% < 50
21
33% 1998 National 2092 pts (National) 46.7 Median age: 52;
50% < 50
22
Morocco 22.30% 1986e1987 5148 pts (hospital-based) * * 29
Oman 13.70% 1993e1997 1809 pts 13 * 8
* 1993 152 pts 15.6 Mean: 48.5; 48%
premenopausal
30
Palestinians 30% 1995 * 13.6 in Arab
women vs. 102.2
in Jews
* 31
* 1994e1999 65 pts 51.5 32
Syria 30% 1998e1999 (1 year) 230 pts 30.4 * 38
* * * * * 39
Tunisia * 1994 689 pts 16.7 Average age: 50 40
Yemen * 1989e1996 225 pts * 69% below 50 41
*Information not available.Kuwait
Information from the Kuwait Cancer Registry 1998 shows
a total number of cases 454 of whom 258 were women.
Eighty-nine cases were breast cancer (34.4% of female
cases).19 ASR was 32.8/100,000 (increase from 7.6/100,000
women in 1982) and 78% of cases were below the age
of 50.20Lebanon
Publications from 1962 until 200421e27 show breast cancer to
range from23% to 35% of cancer inwomen. Breast cancerwas
the most common cancer in women (33% of cases).21,22,28
Absolute Standardized Incidence Rate (ASR) was 20/
100,000 women per year in 1966,23 30/100,000 women/
year for years 1983e2000,21 and 46.7/100,000 women perTable 2 Stage at presentation and mastectomy rate
Country Mastectomy rate Average tumor
size (cm)
Stage at presentation Ref.
Bahrain * 70% >2 I: 6.8%; II: 51.3%; III: 21.4%;
IV: 11.1%
48
Egypt 79.9e82% * III and; IV: 68% 12,13
Saudi Arabia * * I: 9%; II: 44%; III: 30%; IV: 16% 36
Oman 65% 4.6 III: 34.9%; IV: 15.8% 30
Palestinians 70% 3.9 I: 23%; II: 43%; III: 33%; IV: 2%
(þve LNs 53%)
31
Syria 88% * * 39
Tunisia 82.40% 4.95 T1: 7.2%;T2: 48.9%; T3: 18.5%;
T4: 23.4%; CIS: 3.3%; M1:22.1%
40
*Information not available.
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tion with 49% of cases being below 50 and a median age of
49.8 years. This is in contrast to the USA and Europe where
the median age is around 63 with only 25e30% of patients
under 50 years, and 50% of patients are over 63 years of
age.2 In 2004, the Lebanese Cancer Epidemiology Group
showeda total number of cancers of 4388 ofwhich 2092 cases
were in women. Breast cancer was 33.4%, median age was
52 years and 50% were below age 50.22
Morocco
In a review of 5148 cancer patient files, the authors noted
that cervix uteri cancer was prevalent in 35% of cases and
breast cancer was the second most common, in 22.3% of
cases.29
Oman
Oman had a cancer registry for the period 1993e1997. There
were 4091 cases of cancer (2282 in men, 1809 in women).
Breast cancer was 13.7% of all female cases, with an ASR of
13/100,000.8 In another study,30 breast cancer constituted
13.7% of all female cases. ASR was reported at 15.6/
100,000. The number of cases was 152 and the mean age
was 48.5. Patients tended to present with large tumors.
Palestinians
Studies from the Israel Cancer Registry and Jerusalem area
were reviewed.31,32 Breast cancer accounts for 30% of all
new cases of cancer, and 23% of all cancer death in Israel.
The crude incidence for breast cancer in Israel in 1995 was
13.6/100,000 in Arab women as compared to 102.2/100,000
among Jewish women. Incidence of breast cancer has in-
creased by 93.7% from 1970 up to 1995 in Arab women,
while in the Jewish population the increase was only
31.7%. The authors reported that 11% of the Palestinian
group were younger than 35 years as compared to only 5%
of the two Jewish study groups. Screening mammography
diagnosed breast cancer in 26% of the Ashkenazi group,
13% in the Sephardic group, and only 9% in the Palestinian
group. The mean age of Palestinian women with breast can-
cer was 51.5 years, while for Sephardic Jews (of Asian
origin) it was 53.4  1.5 and for Ashkenazi Jews (of
European origin), 55.9 years. Palestinians tended to present
with larger tumors. Age and ethnicity were not found to be
independent predictors of survival. The authors noted that
tumors in Palestinian women were generally detected by
physical examination and not by the widely available
screening mammography, and late diagnosis was the major
factor related to the higher mortality in the Palestinian
group.31
Saudi Arabia
A National Registry was published 1999 and reported 1430
cases of breast cancer (19.1% of all cases). Mean age at
diagnosis: 48.3 years. No case of only ductal carcinoma in
situ (DCIS) was noted.33 Regional variations in Saudi Arabia
were noted by al Hag et al.34 Primary stages I and II consti-
tuted 53% of cases, stage III 30%, and stage IV 16%.35 Locally
advanced breast cancer was also significant according to
data from KFSHRC (King Faysal Specialist Hospital and
Research Center) in Riyadh36 and constituted 40% of all
non-metastatic breast cancer. Bin Yousef et al.37 reportedan interesting observation on Outreach efforts of KFSHRC
with peripheral hospitals, and noted an increased rate of
use of mammography and increased utilization of FNA/core
biopsies for preoperative diagnosis.
Syria
There are no national statistics available. The rate of
breast-conserving surgery was reported to be 18%, while
88% of patients still undergo mastectomy. Syrian surgeons
relate this to the fact that radiation therapy machines are
located only in the capital, and to the presence of larger
tumors at presentation.38 An ASR of 30.4 was reported from
a regional study from Aleppo, Syria39 and is included in
Table 1.
Tunisia
All breast cancers in Tunisia seen in 1994 constituted 689
new cases. The ASR was calculated at 16.7/100,000.
Average age was 50 years. Average tumor size was noted
at 49.5 mm. Only 3.3% of cases were in situ cancers.
Breast-conserving surgery was done only in 17.6%.
Twenty-two percent were metastatic at presentation.40
Yemen
There was only a retrospective study from the University
Hospital in Yemen.41 Two hundred and twenty-seven pa-
tients were seen between 1989 and 1998 of whom 225
were women. Sixty-nine percent were below the age of
50. Positive lymph nodes were present in 90% of cases.41
Breast cancer screening
Screening in Lebanon, for example, reflects the situation in
most Arab countries. There are no national programs for
screening. Women who undergo screening mammography
are usually self-motivated or referred by a motivated
physician. Governmental and private insurers do not usually
cover the expenses of screening mammography. Most
governments do not monitor mammography centers either
for safety or for results. This remains a matter of in-
stitutional internal policies. There have been several
awareness campaigns at the occasion of October Breast
Cancer Month. These awareness campaigns involve media
interventions and interviews by physicians, media adver-
tisements, street posters and public lectures. In 2003 and
2004, campaigns involved soliciting and offering screening
mammography in scattered centers at a reduced price.
Rates of partial vs. total mastectomies
Modified radical mastectomy (MRM) remains the most
commonly performed operation for Arab women with
breast cancer (see Table 2). Awareness campaigns in Leba-
non have reduced the rates of locally advanced disease and
a recent study from AUBMC on 1328 patients showed that
the rate of mastectomy was 90% in 1990 and became 45%
in 2001 (El Saghir, et al. unpublished data). The Cairo Breast
Cancer Screening Trial resulted in more early detection and
an improved rate of breast-conserving surgery.14,16 In Syria,
MRM was 88% and a major reason for this practice is the
presence of one radiation therapy center in Damascus for
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serving surgery was done only in 17.6%.40
Clinical trials
Other than phase II trials, several physicians and centers
(Egypt, Kuwait, Lebanon, Saudi Arabia and others) partic-
ipate in international phase III trials such as with EORTC and
Breast cancer research groups.
Radiation therapy
Radiation therapy is an essential modality for the treat-
ment of breast cancer. Availability of modern radiation
oncology units in various parts of each country allows for
the practice of breast-conservation surgery where surgical
expertise exists. Based on our field knowledge, and data
from the International Atomic Energy Agency (IAEA), we
were able to obtain information on several Arabic coun-
tries and compare them with neighboring countries,
Europe and the United States.42 Table 3 shows that the
availability of radiotherapy services in the Arab world is
far below international standards and varies significantly
among different countries. In addition, there is a large
gap between many Arab countries and the industrialized
nations. For instance, in the Arab world there is an aver-
age of one linear accelerator (Linac) per 4.3 million per-
sons compared to one Linac per 0.149 million in
industrialized countries like the United States, France
and Australia. The gap also exists, but to a lesser degree,
with neighboring non-Arab countries like Israel, Cyprus and
Turkey (1 Linac per 1.495 million persons). The shortage
also extends to health care providers and support person-
nel like medical physicists and radiation therapy technolo-
gists (Table 3). In a comparison between Arab countries
and the USA, which have equivalent population numbers
around 300 million, Arab countries combined have only
84 radiation therapy centers while the USA has 1875,
Arab countries have 256 radiation oncologists while the
USA has 3068, and Arab countries have 473 radiation tech-
nologists while the USA has 5155 (Table 4).
Discussion
Breast cancer incidence rates
ASR for Arab countries vary between those from industri-
alized nations and less developed countries. Median age at
presentation is around 50 years and there are increased
percentages of younger-aged groups at presentation.
Age-adjusted incidence rates for breast cancer in many
Arab countries such as Lebanon (from 20 in 1996 to 46.7
in 1998), Jordan (ASR increase from 7.6/100,000 women
in 1982 to 32.8/100,000 in 1997), Palestinians (up 93%),
and Egypt up to an ASR of 49.6.11 Although the rates are
still below those in industrialized nations, they are rising
and may be expected to reach the same levels. Changes
may be due to westernized lifestyle changes including di-
etary habits, lack of exercise and urbanization, and delay
of ages of marriage and first pregnancy from the lateteens and early twenties to the late twenties in many
Arab countries. Increase in breast cancer incidence is
noted worldwide.43 However, many Arab countries still
need National and Regional Cancer Registries that issue
regular updates. Adequate Mortality records and disease-
specific mortality rates are still missing in almost
all Arab countries. Research into etiological factors re-
mains minimal. Very few reports exist on BRCA1 and
BRCA244e47 from Tunisia and Jordan, and no conclusions
could be made on the prevalence or frequency of muta-
tions among Arab women.
Breast cancer early detection and screening
Breast cancer awareness campaigns increase women’s
individual motivation and private physician’s initiative for
higher indices of suspicion and early diagnosis. Although in
some specialized centers there are an increasing number of
women presenting with early breast cancer and even DCIS,
large numbers of women still present with locally advanced
and metastatic breast cancer in most Arab countries.
Reasons for this include fear of cancer, shyness, poor
health education and difficult access to health care
facilities. Therefore, most Arab countries should aim at
decreasing the incidence of large tumors and advanced
disease at presentation. The application of international
guidelines has to be adapted to local circumstances, and
breast cancer programs should have a goal of diagnosis at
early stages.49
Screening mammography recommendations
While the majority of countries with limited resources
should aim at discovering cancer at early stages, those
Arab countries with adequate or abundant resources could
adopt population-based screening mammography pro-
grams. Screening mammography is recommended for
women over the age of 50 years; however, many authorities
also recommend that screening mammography be started
at age 40.50 In view of younger ages at presentation in
Arab Countries, it is reasonable to adopt recommendations
to start at the age of 40 in those countries with adequate
resources and where setups for benefit from early detec-
tion are available. Mammography centers should be sub-
jected to inspection for radiation emission, technician
skills, film development and reading, and should be re-
quired to have certification and licensing renewal every
year. Breast cancer-related mortality rates have started
to decrease in the United States, Canada, and some
European countries because of widespread population
screening, better awareness, and advances in therapy.
Arab countries should aim at reducing locally advanced
and metastatic breast cancer at presentation and discover
it early in order to reduce morbidity and mortality from
breast cancer.
Role of husbands in early detection and screening
Practicing surgeons and medical oncologists routinely see
young women presenting with large breast tumors. Large
Radiat.
Oncologists
Med.
Physicians
Radiat.
Technologists
10 13 18
0 0 0
11 5 22
22 10 34
9 5 24
6 10 20
20 9 41
133 71 209
2 5 6
25 4 28
10 2 34
8 4 37
256 138 473
21.33 11.50 39.42
0.85 0.46 1.57
1177 2183 637
17 24 61
9 8 18
234 95 259
260 127 338
86.67 42.33 112.67
3.22 1.57 4.19
311 636 239
161 127 731
565 287 201
3068 1926 5155
3794 2340 6087
1264.67 780.00 2029.00
10.01 6.18 16.07
100 162 62
therapy Centers (DIRAC), September 2004.
230
N
.S.
E
l
Sa
gh
ir
e
t
a
l.Table 3 Availability of radiotherapy in Arab countries
Country Population
(103)
RT Centers Linacs 60Co LA and 60Co Simul. Brachytherapy
Iraq 28807 2 2 2
Jordan 5703 4 5 4 9 2 1
Kuwait 2687 2 1 2 3 0
Lebanon 3577 6 9 4 13 4 1
Qatar 813 2 0
Saudi Arabia 24573 8 16 2 18 2 4
Syria 19043 2 1 4 5 2 1
United Arab Emirates 4496 2 4 2 6 2 2
Yemen 20975 1 1 1 0
Algeria 32854 7 6 12 18 5
Egypt 74033 27 20 20 12 2
Libyan Arab Jamahiriya 5853 7 21 6 27 3 2
Morocco 31478 6 3 5 8 3 22
Tunisia 10102 6 2 7 9 3 5
Sudan 36233 2 2 3 5 2 1
Total 301227 84 70 74 144 40 41
Average/Country 20081.80 5.60 6.36 5.29 10.29 2.86 4.10
Average/1000 0.28 0.23 0.25 0.48 0.13 0.14
Ratio 3586 4303 4071 2092 7531 7347
Neighboring countries
Israel 6725 16 22 7 29 4 3
Cyprus 835 2 2 2 4 1 1
Turkey 73193 40 30 47 77 31 4
Total 80753 58 54 56 110 36 8
Average/Country 26917.67 19.33 18.00 18.67 36.67 12.00 2.67
Average/1,000,000 0.72 0.67 0.69 1.36 0.45 0.10
Ratio 1392 1495 1442 734 2243 10094
Industrialized nations
Australia 20155 34 110 1 29 29 24
France 60496 195 291 110 157 157 25
United States of America 298213 1875 2133 166 1058 1058 238
Total 378864 2104 2534 277 1244 1244 287
Average/Country 126288.00 701.33 844.67 92.33 414.67 414.67 95.67
Average/1,000,000 5.55 6.69 0.73 3.28 3.28 0.76
Ratio 180 150 1368 305 305 1320
RatioZ number of people covered per unit of equipment (or physician). Sources: International Atomic Energy Agency. Directory of Radio
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as noted above. These large tumors could be easily felt
by the young woman or her husband. However, fear of
cancer, shyness, family restrictions and fear of social im-
plications, as well as poor health education and difficulty
of access to breast health care, may be reasons for de-
lays in presentation and diagnosis. Advanced breast can-
cer can be devastating not only to the woman,
especially a young woman, but also to all her family
and particularly her husband and children. We recom-
mend that awareness campaigns should be also directed
toward husbands. Husbands should be asked to encourage
their wives to enroll in awareness and screening
campaigns.
Radiation therapy in the Arab world
We have shown that modern radiation therapy is available
only in select centers, and varies from country to country
and from region to region. This shortage negatively affects
the feasibility of modern treatment approaches of all
cancers, including breast cancer conservation surgery and
adjuvant radiation therapy. Our study shows the de-
ficiencies and investment in technical equipment and
human resources is needed. Early diagnosis of breast
cancer requires the availability of more radiation facilities
in order to reduce the unacceptable current rate of
mastectomy in Arab countries. The recently reported
short-term methods of delivering targeted intraoperative
radiation therapy (Targit)51 from the University College
London Hospital, London, UK and Electron Intra-Operative
Radiation Therapy (ELIOT)52 from the European Institute
of Oncology of Milan, Italy in one session, or one intra-op-
erative session followed by 12 external radiation therapy
sessions in women below age 48 years,53 may be reason-
able options in some large countries where most patients
have to travel long distances to receive radiation therapy
daily for 5e6 weeks.
Multi-disciplinary management of breast cancer
in the Arab world
Of the many things that are taken for granted in Europe,
USA, Australia and the rest of the industrialized world is the
multidisciplinary approach to cancer management. Cur-
rently, very few centers practice it in developing and Arab
countries. Access to multi-disciplinary tumor boards and
clinics will improve breast cancer care. Development of
centralized, specialized cancer centers may be a cost-
effective way to deliver breast cancer care to some women
when it is not possible to deliver such care to women
Table 4 Comparison of radiation therapy facilities and
resources between Arab countries and USA
Countries Population RT
Centers
Radiation
oncologists
Radiation
technologists
Arab 301,227,000 84 256 473
USA 298,213,000 1875 3068 5155nationwide according to the Global Summit Consensus
Conference.49 A few cancer centers exist in Arab countries
and many more are needed.
Conclusions
Breast cancer has become a curable cancer, with reduced
toxicity and less breast deformity in larger numbers of
women, in industrialized nations but only so in a small
number in the Arab world. Breast cancer is the most
common cancer in Arabic women and affects younger
women than their counterparts in industrialized nations.
Collecting data on breast cancer is imperative for deciding
how best to apply resources. National and regional cancer
registries are still lacking in many countries. Although
population screening may be feasible in some countries
with abundant-resources, it is not practical in most Arab
countries with large populations and truly limited re-
sources. In fact, breast cancer mortality can be reduced
if disease is diagnosed at earlier stages. Panelists of the
Global Summit Consensus Conference noted that measures
to educate the public and health care providers about
breast health and breast cancer detection, diagnosis, and
treatment are considered more important than screening
in countries with limited resources.49 Development of cen-
tralized, specialized cancer centers may be a cost-effec-
tive way to deliver breast cancer care to some women
when it is not possible to deliver such care to women na-
tionwide.49 Awareness campaigns and screening should be
applied according to resources. Awareness campaigns
should also be directed at husbands to encourage women
to enroll in early detection programs. Radiation therapy
facilities and manpower remain very limited and deserve
better planning and investment, and to be more widely
available and distributed in major cities and distant
regions.
Medical development in the Arab world has not fol-
lowed urban development in the last 50 years. The Arab
world cannot be conceived collectively as a number of
countries with limited resources. Whereas some of the
Arab countries have truly limited resources, others have
abundant resources and most of them could benefit from
better allocation of these resources. Medical research,
including cancer research, deserves to be given priority
in the Arab world. Research into etiology, local character-
istics and new therapies should be further developed.
Women’s rights movements in the Arab world ought to
put breast cancer, amongst other women’s health issues,
on their agenda. The medical community in the Arab World
is urged to publish its findings in peer-reviewed scientific
journals.
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